Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity By: Benzinga via Benzinga February 24, 2015 at 16:00 PM EST In a report published Monday, Canaccord Genuity analyst Neil Maruoka commented that Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is ... Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.